Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.
Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.
批准号:
11671990
负责人:
HARADA Koji
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have investigated the expression of p27^<Kip1> in oral squamous cell carcinomas (OSCCs) using immunohistochemistry and have tried to investigate the relationship between each expression level and clinico-pathological characteristics such as tumor grade, T, N, stage classifications, effect and outcome. High levels of p27^<Kip1> expression were significantly related to well differentiated cases(p<0.05), NO cases (p<0.01), non advanced cases (p<0.01), and good effective cases (p<0.05). Five-year survival rate of p27^<Kip1> high expression cases was 63.3%, and it was significantly high than that of p27^<Kip1> low expression cases (45.5%) (p<0.05). By Cox's proportional hazards model, high levels of p27^<Kip1> expression significantly made the rate of death decrease. These results suggested that p27^<Kip1> protein expression may be closely related to tumor grade, inhibition of metastasis, effect and outcome, and an useful prognostic marker. Next, we have constructed p27^<Kip1> expression vectors with pcDNA3.1 (stratagene). Moreover, we transfected them to OSCC cell line (B88) in sense or anti-sense oriented, and tried to regulate the p27^<Kip1> gene in B88 cells. Overexpression of p27^<Kip1> in B88 cells (B88/Tp27sense) inhibited the growth, invasion and metastasis of them. Contradictory, low expression of p27^<Kip1> in B88 cells (B88/Tp27anti-sense) promoted the growth, invasion and metastasis. On tumor differentiation, we could detect the morphological change from squamous cell type to spindol cell type in B88/Tp27anti-sense though we could not detect the difference between parental B88 and B88/Tp27sense by HE staining. Moreover, we could detect the induction of involucrin and keratin 7,8 (Cam 5.2) in B88/Tp27sense immunohistochemically. These results suggested that p27^<Kip1> might be related to terminal differentiation of OSSC.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Carlile J: "VEGF expression in oral tissues, Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. (in press).
Carlile J:“口腔组织中的 VEGF 表达,可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Harada K, Lu S, Chisholm MD, Syrjnen S and Schor AM: "Angiogenesis and vasodilation in skin warts. Association with HPV infection."Anticancer Res. 20. 4519-4524 (2000)
Harada K、Lu S、Chisholm MD、Syrjnen S 和 Schor AM:“皮肤疣中的血管生成和血管舒张。与 HPV 感染的关联。”抗癌研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Motegi K: "Effect of a mutant form of 1kB-α on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells."Oral Oncol, Eur J Cancer. 37. 185-192 (2001)
Motegi K:“1kB-α 突变体对转化人唾液腺细胞中 5-氟尿嘧啶诱导的细胞凋亡的影响。”Oral Oncol,Eur J Cancer 37. 185-192 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Harada K and Ogden GR: "An overview of the cell cycle arrest protein p21^<WAF1>"Oral Oncol, Eur J Cancer. 36. 3-7 (2000)
Harada K 和 Ogden GR:“细胞周期阻滞蛋白 p21^<WAF1> 的概述”Oral Oncol,Eur J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Carlile J, Harada K, Baillie R, Macluskey M, Chisholm DM, Ogden GR, Schor SL, Schor AM: "VEGF expression in oral tissues. Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. 30 (in press).
Carlile J、Harada K、Baillie R、Macluskey M、Chisholm DM、Ogden GR、Schor SL、Schor AM:“口腔组织中的 VEGF 表达。可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Development of novel treatment against refractory oral cancer by uptake inhibition of iron or induction of ferroptosis
-
批准号:18K09814
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2018
-
负责人:HARADA Koji
-
依托单位:
Development of new oral cancer treatments focused on mTOR inhibition leading to the anti-aging prevention and the healthy life-span extension
-
批准号:15K11292
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:HARADA Koji
-
依托单位:
Development of a novel functional preservation therapy against advanced, recurrent or unresectable oral cancers.
-
批准号:24593034
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:HARADA Koji
-
依托单位:
Examination of the physical pictures of the field theories with nonlinearly realized symmetries by the Wilsonian renormalization group method
-
批准号:22540286
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.83万
-
财政年份:2010
-
负责人:HARADA Koji
-
依托单位:
A fundamental research on a new AIDS treatment based on an error rate control of HIV-1 reverse transcriptase
-
批准号:22500273
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2010
-
负责人:HARADA Koji
-
依托单位:
Identification of new predictive factors for chemo-radiation against oral cancers and setting of individualized medicine based on their expressions
-
批准号:21592555
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:HARADA Koji
-
依托单位:
Development of the therapy for oral cancer by S-1 and proteasome inhibitor in combination with concurrent radiotherapy
-
批准号:19592339
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:HARADA Koji
-
依托单位:
Understanding a mechanism of HIV-1 drug resistance development under the RTI pressure and the development of a medication scheduling system
-
批准号:18700293
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.72万
-
财政年份:2006
-
负责人:HARADA Koji
-
依托单位:
Development of molecular targeting therapy against stability of p27^<Kip1> protein in oral squamous cell carcinoma.
-
批准号:17592089
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HARADA Koji
-
依托单位:
Development of molecular targeting therapy against p27^<Kip1> in oral squamous cell carcinoma.
-
批准号:15592116
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:HARADA Koji
-
依托单位:
海外基金